Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil.

Although there was a higher proportion of patients in private hospitals versus public hospitals receiving third-line therapy, this difference did not reach statistical significance (3% v 2%; P = .16).

also in 111,027 other papers

As noted in Fig 2A , sunitinib and pazopanib were the most frequently used first-line therapies throughout the study period, and a significant trend toward increasing use of pazopanib and decreasing use of sunitinib was observed.

also in 9,775 other papers